Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1146554C details a scalable route for Formula I and XIV intermediates. Eliminates chromatography, improves yield via dynamic resolution. Ideal for API manufacturing cost reduction.
Novel metal-catalyzed process for 1-beta-methyl carbapenem intermediates. High yield, mild conditions, scalable production for global supply chains.
Patent CN1525964A reveals a novel high-purity Biperiden synthesis route. Discover cost-effective manufacturing solutions for Parkinson's disease API intermediates with superior stereocontrol.
Novel route for GABA-T inhibitor precursor via lactam rearrangement offering cost reduction and scalable pharmaceutical intermediate manufacturing solutions.
Advanced stereoselective synthesis of Phencyclonate optical isomers via Mandelic acid template. Superior purity and scalable route for pharmaceutical manufacturing.
Novel semi-synthesis of paclitaxel and docetaxel using trans-chiral side chains and stereochemical inversion. High yield, industrial scale potential.
Advanced stereoselective synthesis of Hyphantria cunea sex pheromones via CN101798293B. Delivers high enantiomeric excess and scalable agrochemical intermediate manufacturing.
Patent CN1379754A reveals a novel selective nitration route for 5-nitrobenzofuran intermediates, offering cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN113754650A reveals a novel route for rosuvastatin calcium intermediates, drastically reducing cis-isomer impurities and enhancing pharmaceutical manufacturing efficiency.
Patent CN111393329A details a high-yield synthesis of BDH, a key ritonavir intermediate, utilizing stereoselective reduction for cost-effective manufacturing.
Patent CN110845388A reveals a novel 3-step synthesis of 7-nitroindole from o-nitroaniline. Discover cost-effective, scalable production methods for high-purity intermediates.
Novel synthesis method for Syk inhibitor intermediate via selective nitration and hydrazine reduction, offering high yield and scalability for pharma supply chains.
Patent CN112661802B reveals a scalable, non-toxic route for 3'-methoxyguanosine, offering significant cost reduction and supply chain reliability for mRNA cap analog manufacturing.
Discover a cost-effective synthesis of ganaxolone via direct methylation. Enhanced purity and supply chain reliability for pharmaceutical intermediates.
Novel patent CN104109182A details high purity gemcitabine hydrochloride synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102348706A details a novel selective acylation method for pyripyropene derivatives, offering significant cost reduction and improved purity for agrochemical manufacturing.
Patent CN1269795A reveals a scalable route for chiral alkoxyfuranone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel stereoselective route for tea geometrid sex pheromone using cheap diol. High yield, >98% ee, scalable for green pest control supply chains.
Patent CN113527388A details a novel DPPA-mediated method for beta-2-deoxy sugar synthesis, offering high stereoselectivity and mild conditions for API manufacturing.
Novel method replaces Claisen condensation for high-purity dioxane acetate intermediates. Significantly reduces production costs and improves scalability for global statin manufacturers.